Global Fam-Trastuzumab Deruxtecan Market Growth 2026-2032
The global Fam-Trastuzumab Deruxtecan market size is predicted to grow from US$ 4278 million in 2025 to US$ 17575 million in 2032; it is expected to grow at a CAGR of 18.5% from 2026 to 2032.
Fam-Trastuzumab Deruxtecan (T-DXd) is a new-generation human epidermal growth factor receptor 2 (HER2)-targeted antibody-drug conjugate (ADC). It is covalently composed of a humanized anti-HER2 monoclonal antibody, a cleavable tetrapeptide linker, and DXd, a topoisomerase I inhibitor, with a high drug-to-antibody ratio of 8:1. The drug specifically binds to the HER2 receptor on the surface of tumor cells, and releases highly potent cytotoxic payloads after internalization into cells. It exerts a strong anti-tumor effect by inhibiting DNA replication and inducing apoptosis, and also exhibits a bystander killing effect, showing significant activity against HER2-low expressing tumors. Clinically, it is mainly used for the treatment of solid tumors such as HER2-positive breast cancer, gastric cancer, esophageal cancer and non-small cell lung cancer. With excellent efficacy and favorable safety, it has become a landmark anti-tumor drug with the broadest indications and outstanding clinical value among global ADCs.In 2025, global Fam-Trastuzumab Deruxtecan production reached approximately 4,373,000 vials.
As a benchmark product in the global ADC drug sector, fam-trastuzumab deruxtecan has become a core therapeutic option for HER2-positive solid tumors due to its superior clinical efficacy, broad indication layout, and leading technological advantages. Its market position is supported by multiple barriers: in terms of efficacy, the drug is not only the gold standard for second-line treatment of HER2-positive breast cancer but also pioneeringly covers HER2-low expressing populations, significantly expanding its applicable scope. In indication expansion, it has been approved for multiple cancers including breast cancer, gastric cancer, and non-small cell lung cancer, with ongoing research in early-stage treatment and combination therapy. Commercially, it has achieved rapid global penetration, and its accessibility in China has greatly improved after inclusion in medical insurance, making it a core growth engine.
In the current competitive landscape, fam-trastuzumab deruxtecan maintains an absolutely dominant position. Although facing competition from domestic agents such as disitamab vedotin and ado-trastuzumab emtansine in China, it retains a stable market share owing to its advantages in efficacy and breadth of indications. In the future, with the approval of new indications, deeper deployment in early treatment, and wider medical insurance coverage worldwide, its market potential will be further unlocked. Meanwhile, the rapid rise of domestic ADC drugs will intensify competition, forcing it to consolidate its leading position through technological upgrading, price optimization, and differentiated strategies.
LP Information, Inc. (LPI) ' newest research report, the ?Fam-Trastuzumab Deruxtecan Industry Forecast? looks at past sales and reviews total world Fam-Trastuzumab Deruxtecan sales in 2025, providing a comprehensive analysis by region and market sector of projected Fam-Trastuzumab Deruxtecan sales for 2026 through 2032. With Fam-Trastuzumab Deruxtecan sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Fam-Trastuzumab Deruxtecan industry.
This Insight Report provides a comprehensive analysis of the global Fam-Trastuzumab Deruxtecan landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Fam-Trastuzumab Deruxtecan portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Fam-Trastuzumab Deruxtecan market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Fam-Trastuzumab Deruxtecan and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Fam-Trastuzumab Deruxtecan.
This report presents a comprehensive overview, market shares, and growth opportunities of Fam-Trastuzumab Deruxtecan market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Fam-Trastuzumab Deruxtecan market?
What factors are driving Fam-Trastuzumab Deruxtecan market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Fam-Trastuzumab Deruxtecan market opportunities vary by end market size?
How does Fam-Trastuzumab Deruxtecan break out by Type, by Application?
Fam-Trastuzumab Deruxtecan (T-DXd) is a new-generation human epidermal growth factor receptor 2 (HER2)-targeted antibody-drug conjugate (ADC). It is covalently composed of a humanized anti-HER2 monoclonal antibody, a cleavable tetrapeptide linker, and DXd, a topoisomerase I inhibitor, with a high drug-to-antibody ratio of 8:1. The drug specifically binds to the HER2 receptor on the surface of tumor cells, and releases highly potent cytotoxic payloads after internalization into cells. It exerts a strong anti-tumor effect by inhibiting DNA replication and inducing apoptosis, and also exhibits a bystander killing effect, showing significant activity against HER2-low expressing tumors. Clinically, it is mainly used for the treatment of solid tumors such as HER2-positive breast cancer, gastric cancer, esophageal cancer and non-small cell lung cancer. With excellent efficacy and favorable safety, it has become a landmark anti-tumor drug with the broadest indications and outstanding clinical value among global ADCs.In 2025, global Fam-Trastuzumab Deruxtecan production reached approximately 4,373,000 vials.
As a benchmark product in the global ADC drug sector, fam-trastuzumab deruxtecan has become a core therapeutic option for HER2-positive solid tumors due to its superior clinical efficacy, broad indication layout, and leading technological advantages. Its market position is supported by multiple barriers: in terms of efficacy, the drug is not only the gold standard for second-line treatment of HER2-positive breast cancer but also pioneeringly covers HER2-low expressing populations, significantly expanding its applicable scope. In indication expansion, it has been approved for multiple cancers including breast cancer, gastric cancer, and non-small cell lung cancer, with ongoing research in early-stage treatment and combination therapy. Commercially, it has achieved rapid global penetration, and its accessibility in China has greatly improved after inclusion in medical insurance, making it a core growth engine.
In the current competitive landscape, fam-trastuzumab deruxtecan maintains an absolutely dominant position. Although facing competition from domestic agents such as disitamab vedotin and ado-trastuzumab emtansine in China, it retains a stable market share owing to its advantages in efficacy and breadth of indications. In the future, with the approval of new indications, deeper deployment in early treatment, and wider medical insurance coverage worldwide, its market potential will be further unlocked. Meanwhile, the rapid rise of domestic ADC drugs will intensify competition, forcing it to consolidate its leading position through technological upgrading, price optimization, and differentiated strategies.
LP Information, Inc. (LPI) ' newest research report, the ?Fam-Trastuzumab Deruxtecan Industry Forecast? looks at past sales and reviews total world Fam-Trastuzumab Deruxtecan sales in 2025, providing a comprehensive analysis by region and market sector of projected Fam-Trastuzumab Deruxtecan sales for 2026 through 2032. With Fam-Trastuzumab Deruxtecan sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Fam-Trastuzumab Deruxtecan industry.
This Insight Report provides a comprehensive analysis of the global Fam-Trastuzumab Deruxtecan landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Fam-Trastuzumab Deruxtecan portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Fam-Trastuzumab Deruxtecan market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Fam-Trastuzumab Deruxtecan and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Fam-Trastuzumab Deruxtecan.
This report presents a comprehensive overview, market shares, and growth opportunities of Fam-Trastuzumab Deruxtecan market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- 5.4 mg/kg
- 6.4 mg/kg
- Monoclonal Antibody
- Polyclonal Antibody
- Lyophilized Powder For Injection
- Concentrate For Intravenous Infusion
- Innovator
- Generic
- HER2-Positive Breast Cancer
- HER2-Positive Gastric and Gastroesophageal Junction Cancer
- HER2-Mutant Non-Small Cell Lung Cancer
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Daiichi Sankyo
- AstraZeneca
What is the 10-year outlook for the global Fam-Trastuzumab Deruxtecan market?
What factors are driving Fam-Trastuzumab Deruxtecan market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Fam-Trastuzumab Deruxtecan market opportunities vary by end market size?
How does Fam-Trastuzumab Deruxtecan break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Fam-Trastuzumab Deruxtecan Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Fam-Trastuzumab Deruxtecan by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Fam-Trastuzumab Deruxtecan by Country/Region, 2021, 2025 & 2032
2.2 Fam-Trastuzumab Deruxtecan Segment by Type
2.2.1 5.4 mg/kg
2.2.2 6.4 mg/kg
2.2.3 Fam-Trastuzumab Deruxtecan Sales by Type
2.2.3.1 Global Fam-Trastuzumab Deruxtecan Sales Market Share by Type (2021-2026)
2.2.3.2 Global Fam-Trastuzumab Deruxtecan Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Fam-Trastuzumab Deruxtecan Sale Price by Type (2021-2026)
2.3 Fam-Trastuzumab Deruxtecan Segment by Antibody Type
2.3.1 Monoclonal Antibody
2.3.2 Polyclonal Antibody
2.3.3 Fam-Trastuzumab Deruxtecan Sales by Antibody Type
2.3.3.1 Global Fam-Trastuzumab Deruxtecan Sales Market Share by Antibody Type (2021-2026)
2.3.3.2 Global Fam-Trastuzumab Deruxtecan Revenue and Market Share by Antibody Type (2021-2026)
2.3.3.3 Global Fam-Trastuzumab Deruxtecan Sale Price by Antibody Type (2021-2026)
2.4 Fam-Trastuzumab Deruxtecan Segment by Dosage Form
2.4.1 Lyophilized Powder For Injection
2.4.2 Concentrate For Intravenous Infusion
2.4.3 Fam-Trastuzumab Deruxtecan Sales by Dosage Form
2.4.3.1 Global Fam-Trastuzumab Deruxtecan Sales Market Share by Dosage Form (2021-2026)
2.4.3.2 Global Fam-Trastuzumab Deruxtecan Revenue and Market Share by Dosage Form (2021-2026)
2.4.3.3 Global Fam-Trastuzumab Deruxtecan Sale Price by Dosage Form (2021-2026)
2.5 Fam-Trastuzumab Deruxtecan Segment by Production Technology
2.5.1 Innovator
2.5.2 Generic
2.5.3 Fam-Trastuzumab Deruxtecan Sales by Production Technology
2.5.3.1 Global Fam-Trastuzumab Deruxtecan Sales Market Share by Production Technology (2021-2026)
2.5.3.2 Global Fam-Trastuzumab Deruxtecan Revenue and Market Share by Production Technology (2021-2026)
2.5.3.3 Global Fam-Trastuzumab Deruxtecan Sale Price by Production Technology (2021-2026)
2.6 Fam-Trastuzumab Deruxtecan Segment by Application
2.6.1 HER2-Positive Breast Cancer
2.6.2 HER2-Positive Gastric and Gastroesophageal Junction Cancer
2.6.3 HER2-Mutant Non-Small Cell Lung Cancer
2.6.4 Others
2.6.5 Fam-Trastuzumab Deruxtecan Sales by Application
2.6.5.1 Global Fam-Trastuzumab Deruxtecan Sale Market Share by Application (2021-2026)
2.6.5.2 Global Fam-Trastuzumab Deruxtecan Revenue and Market Share by Application (2021-2026)
2.6.5.3 Global Fam-Trastuzumab Deruxtecan Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Fam-Trastuzumab Deruxtecan Breakdown Data by Company
3.1.1 Global Fam-Trastuzumab Deruxtecan Annual Sales by Company (2021-2026)
3.1.2 Global Fam-Trastuzumab Deruxtecan Sales Market Share by Company (2021-2026)
3.2 Global Fam-Trastuzumab Deruxtecan Annual Revenue by Company (2021-2026)
3.2.1 Global Fam-Trastuzumab Deruxtecan Revenue by Company (2021-2026)
3.2.2 Global Fam-Trastuzumab Deruxtecan Revenue Market Share by Company (2021-2026)
3.3 Global Fam-Trastuzumab Deruxtecan Sale Price by Company
3.4 Key Manufacturers Fam-Trastuzumab Deruxtecan Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Fam-Trastuzumab Deruxtecan Product Location Distribution
3.4.2 Players Fam-Trastuzumab Deruxtecan Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR FAM-TRASTUZUMAB DERUXTECAN BY GEOGRAPHIC REGION
4.1 World Historic Fam-Trastuzumab Deruxtecan Market Size by Geographic Region (2021-2026)
4.1.1 Global Fam-Trastuzumab Deruxtecan Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Fam-Trastuzumab Deruxtecan Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Fam-Trastuzumab Deruxtecan Market Size by Country/Region (2021-2026)
4.2.1 Global Fam-Trastuzumab Deruxtecan Annual Sales by Country/Region (2021-2026)
4.2.2 Global Fam-Trastuzumab Deruxtecan Annual Revenue by Country/Region (2021-2026)
4.3 Americas Fam-Trastuzumab Deruxtecan Sales Growth
4.4 APAC Fam-Trastuzumab Deruxtecan Sales Growth
4.5 Europe Fam-Trastuzumab Deruxtecan Sales Growth
4.6 Middle East & Africa Fam-Trastuzumab Deruxtecan Sales Growth
5 AMERICAS
5.1 Americas Fam-Trastuzumab Deruxtecan Sales by Country
5.1.1 Americas Fam-Trastuzumab Deruxtecan Sales by Country (2021-2026)
5.1.2 Americas Fam-Trastuzumab Deruxtecan Revenue by Country (2021-2026)
5.2 Americas Fam-Trastuzumab Deruxtecan Sales by Type (2021-2026)
5.3 Americas Fam-Trastuzumab Deruxtecan Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Fam-Trastuzumab Deruxtecan Sales by Region
6.1.1 APAC Fam-Trastuzumab Deruxtecan Sales by Region (2021-2026)
6.1.2 APAC Fam-Trastuzumab Deruxtecan Revenue by Region (2021-2026)
6.2 APAC Fam-Trastuzumab Deruxtecan Sales by Type (2021-2026)
6.3 APAC Fam-Trastuzumab Deruxtecan Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Fam-Trastuzumab Deruxtecan by Country
7.1.1 Europe Fam-Trastuzumab Deruxtecan Sales by Country (2021-2026)
7.1.2 Europe Fam-Trastuzumab Deruxtecan Revenue by Country (2021-2026)
7.2 Europe Fam-Trastuzumab Deruxtecan Sales by Type (2021-2026)
7.3 Europe Fam-Trastuzumab Deruxtecan Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Fam-Trastuzumab Deruxtecan by Country
8.1.1 Middle East & Africa Fam-Trastuzumab Deruxtecan Sales by Country (2021-2026)
8.1.2 Middle East & Africa Fam-Trastuzumab Deruxtecan Revenue by Country (2021-2026)
8.2 Middle East & Africa Fam-Trastuzumab Deruxtecan Sales by Type (2021-2026)
8.3 Middle East & Africa Fam-Trastuzumab Deruxtecan Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Fam-Trastuzumab Deruxtecan
10.3 Manufacturing Process Analysis of Fam-Trastuzumab Deruxtecan
10.4 Industry Chain Structure of Fam-Trastuzumab Deruxtecan
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Fam-Trastuzumab Deruxtecan Distributors
11.3 Fam-Trastuzumab Deruxtecan Customer
12 WORLD FORECAST REVIEW FOR FAM-TRASTUZUMAB DERUXTECAN BY GEOGRAPHIC REGION
12.1 Global Fam-Trastuzumab Deruxtecan Market Size Forecast by Region
12.1.1 Global Fam-Trastuzumab Deruxtecan Forecast by Region (2027-2032)
12.1.2 Global Fam-Trastuzumab Deruxtecan Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Fam-Trastuzumab Deruxtecan Forecast by Type (2027-2032)
12.7 Global Fam-Trastuzumab Deruxtecan Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Daiichi Sankyo
13.1.1 Daiichi Sankyo Company Information
13.1.2 Daiichi Sankyo Fam-Trastuzumab Deruxtecan Product Portfolios and Specifications
13.1.3 Daiichi Sankyo Fam-Trastuzumab Deruxtecan Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Daiichi Sankyo Main Business Overview
13.1.5 Daiichi Sankyo Latest Developments
13.2 AstraZeneca
13.2.1 AstraZeneca Company Information
13.2.2 AstraZeneca Fam-Trastuzumab Deruxtecan Product Portfolios and Specifications
13.2.3 AstraZeneca Fam-Trastuzumab Deruxtecan Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 AstraZeneca Main Business Overview
13.2.5 AstraZeneca Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Fam-Trastuzumab Deruxtecan Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Fam-Trastuzumab Deruxtecan by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Fam-Trastuzumab Deruxtecan by Country/Region, 2021, 2025 & 2032
2.2 Fam-Trastuzumab Deruxtecan Segment by Type
2.2.1 5.4 mg/kg
2.2.2 6.4 mg/kg
2.2.3 Fam-Trastuzumab Deruxtecan Sales by Type
2.2.3.1 Global Fam-Trastuzumab Deruxtecan Sales Market Share by Type (2021-2026)
2.2.3.2 Global Fam-Trastuzumab Deruxtecan Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Fam-Trastuzumab Deruxtecan Sale Price by Type (2021-2026)
2.3 Fam-Trastuzumab Deruxtecan Segment by Antibody Type
2.3.1 Monoclonal Antibody
2.3.2 Polyclonal Antibody
2.3.3 Fam-Trastuzumab Deruxtecan Sales by Antibody Type
2.3.3.1 Global Fam-Trastuzumab Deruxtecan Sales Market Share by Antibody Type (2021-2026)
2.3.3.2 Global Fam-Trastuzumab Deruxtecan Revenue and Market Share by Antibody Type (2021-2026)
2.3.3.3 Global Fam-Trastuzumab Deruxtecan Sale Price by Antibody Type (2021-2026)
2.4 Fam-Trastuzumab Deruxtecan Segment by Dosage Form
2.4.1 Lyophilized Powder For Injection
2.4.2 Concentrate For Intravenous Infusion
2.4.3 Fam-Trastuzumab Deruxtecan Sales by Dosage Form
2.4.3.1 Global Fam-Trastuzumab Deruxtecan Sales Market Share by Dosage Form (2021-2026)
2.4.3.2 Global Fam-Trastuzumab Deruxtecan Revenue and Market Share by Dosage Form (2021-2026)
2.4.3.3 Global Fam-Trastuzumab Deruxtecan Sale Price by Dosage Form (2021-2026)
2.5 Fam-Trastuzumab Deruxtecan Segment by Production Technology
2.5.1 Innovator
2.5.2 Generic
2.5.3 Fam-Trastuzumab Deruxtecan Sales by Production Technology
2.5.3.1 Global Fam-Trastuzumab Deruxtecan Sales Market Share by Production Technology (2021-2026)
2.5.3.2 Global Fam-Trastuzumab Deruxtecan Revenue and Market Share by Production Technology (2021-2026)
2.5.3.3 Global Fam-Trastuzumab Deruxtecan Sale Price by Production Technology (2021-2026)
2.6 Fam-Trastuzumab Deruxtecan Segment by Application
2.6.1 HER2-Positive Breast Cancer
2.6.2 HER2-Positive Gastric and Gastroesophageal Junction Cancer
2.6.3 HER2-Mutant Non-Small Cell Lung Cancer
2.6.4 Others
2.6.5 Fam-Trastuzumab Deruxtecan Sales by Application
2.6.5.1 Global Fam-Trastuzumab Deruxtecan Sale Market Share by Application (2021-2026)
2.6.5.2 Global Fam-Trastuzumab Deruxtecan Revenue and Market Share by Application (2021-2026)
2.6.5.3 Global Fam-Trastuzumab Deruxtecan Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Fam-Trastuzumab Deruxtecan Breakdown Data by Company
3.1.1 Global Fam-Trastuzumab Deruxtecan Annual Sales by Company (2021-2026)
3.1.2 Global Fam-Trastuzumab Deruxtecan Sales Market Share by Company (2021-2026)
3.2 Global Fam-Trastuzumab Deruxtecan Annual Revenue by Company (2021-2026)
3.2.1 Global Fam-Trastuzumab Deruxtecan Revenue by Company (2021-2026)
3.2.2 Global Fam-Trastuzumab Deruxtecan Revenue Market Share by Company (2021-2026)
3.3 Global Fam-Trastuzumab Deruxtecan Sale Price by Company
3.4 Key Manufacturers Fam-Trastuzumab Deruxtecan Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Fam-Trastuzumab Deruxtecan Product Location Distribution
3.4.2 Players Fam-Trastuzumab Deruxtecan Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR FAM-TRASTUZUMAB DERUXTECAN BY GEOGRAPHIC REGION
4.1 World Historic Fam-Trastuzumab Deruxtecan Market Size by Geographic Region (2021-2026)
4.1.1 Global Fam-Trastuzumab Deruxtecan Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Fam-Trastuzumab Deruxtecan Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Fam-Trastuzumab Deruxtecan Market Size by Country/Region (2021-2026)
4.2.1 Global Fam-Trastuzumab Deruxtecan Annual Sales by Country/Region (2021-2026)
4.2.2 Global Fam-Trastuzumab Deruxtecan Annual Revenue by Country/Region (2021-2026)
4.3 Americas Fam-Trastuzumab Deruxtecan Sales Growth
4.4 APAC Fam-Trastuzumab Deruxtecan Sales Growth
4.5 Europe Fam-Trastuzumab Deruxtecan Sales Growth
4.6 Middle East & Africa Fam-Trastuzumab Deruxtecan Sales Growth
5 AMERICAS
5.1 Americas Fam-Trastuzumab Deruxtecan Sales by Country
5.1.1 Americas Fam-Trastuzumab Deruxtecan Sales by Country (2021-2026)
5.1.2 Americas Fam-Trastuzumab Deruxtecan Revenue by Country (2021-2026)
5.2 Americas Fam-Trastuzumab Deruxtecan Sales by Type (2021-2026)
5.3 Americas Fam-Trastuzumab Deruxtecan Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Fam-Trastuzumab Deruxtecan Sales by Region
6.1.1 APAC Fam-Trastuzumab Deruxtecan Sales by Region (2021-2026)
6.1.2 APAC Fam-Trastuzumab Deruxtecan Revenue by Region (2021-2026)
6.2 APAC Fam-Trastuzumab Deruxtecan Sales by Type (2021-2026)
6.3 APAC Fam-Trastuzumab Deruxtecan Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Fam-Trastuzumab Deruxtecan by Country
7.1.1 Europe Fam-Trastuzumab Deruxtecan Sales by Country (2021-2026)
7.1.2 Europe Fam-Trastuzumab Deruxtecan Revenue by Country (2021-2026)
7.2 Europe Fam-Trastuzumab Deruxtecan Sales by Type (2021-2026)
7.3 Europe Fam-Trastuzumab Deruxtecan Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Fam-Trastuzumab Deruxtecan by Country
8.1.1 Middle East & Africa Fam-Trastuzumab Deruxtecan Sales by Country (2021-2026)
8.1.2 Middle East & Africa Fam-Trastuzumab Deruxtecan Revenue by Country (2021-2026)
8.2 Middle East & Africa Fam-Trastuzumab Deruxtecan Sales by Type (2021-2026)
8.3 Middle East & Africa Fam-Trastuzumab Deruxtecan Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Fam-Trastuzumab Deruxtecan
10.3 Manufacturing Process Analysis of Fam-Trastuzumab Deruxtecan
10.4 Industry Chain Structure of Fam-Trastuzumab Deruxtecan
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Fam-Trastuzumab Deruxtecan Distributors
11.3 Fam-Trastuzumab Deruxtecan Customer
12 WORLD FORECAST REVIEW FOR FAM-TRASTUZUMAB DERUXTECAN BY GEOGRAPHIC REGION
12.1 Global Fam-Trastuzumab Deruxtecan Market Size Forecast by Region
12.1.1 Global Fam-Trastuzumab Deruxtecan Forecast by Region (2027-2032)
12.1.2 Global Fam-Trastuzumab Deruxtecan Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Fam-Trastuzumab Deruxtecan Forecast by Type (2027-2032)
12.7 Global Fam-Trastuzumab Deruxtecan Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Daiichi Sankyo
13.1.1 Daiichi Sankyo Company Information
13.1.2 Daiichi Sankyo Fam-Trastuzumab Deruxtecan Product Portfolios and Specifications
13.1.3 Daiichi Sankyo Fam-Trastuzumab Deruxtecan Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Daiichi Sankyo Main Business Overview
13.1.5 Daiichi Sankyo Latest Developments
13.2 AstraZeneca
13.2.1 AstraZeneca Company Information
13.2.2 AstraZeneca Fam-Trastuzumab Deruxtecan Product Portfolios and Specifications
13.2.3 AstraZeneca Fam-Trastuzumab Deruxtecan Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 AstraZeneca Main Business Overview
13.2.5 AstraZeneca Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Fam-Trastuzumab Deruxtecan Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Fam-Trastuzumab Deruxtecan Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 5.4 mg/kg
Table 4. Major Players of 6.4 mg/kg
Table 5. Global Fam-Trastuzumab Deruxtecan Sales by Type (2021-2026) & (Units)
Table 6. Global Fam-Trastuzumab Deruxtecan Sales Market Share by Type (2021-2026)
Table 7. Global Fam-Trastuzumab Deruxtecan Revenue by Type (2021-2026) & ($ million)
Table 8. Global Fam-Trastuzumab Deruxtecan Revenue Market Share by Type (2021-2026)
Table 9. Global Fam-Trastuzumab Deruxtecan Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of Monoclonal Antibody
Table 11. Major Players of Polyclonal Antibody
Table 12. Global Fam-Trastuzumab Deruxtecan Sales by Antibody Type (2021-2026) & (Units)
Table 13. Global Fam-Trastuzumab Deruxtecan Sales Market Share by Antibody Type (2021-2026)
Table 14. Global Fam-Trastuzumab Deruxtecan Revenue by Antibody Type (2021-2026) & ($ million)
Table 15. Global Fam-Trastuzumab Deruxtecan Revenue Market Share by Antibody Type (2021-2026)
Table 16. Global Fam-Trastuzumab Deruxtecan Sale Price by Antibody Type (2021-2026) & (US$/Unit)
Table 17. Major Players of Lyophilized Powder For Injection
Table 18. Major Players of Concentrate For Intravenous Infusion
Table 19. Global Fam-Trastuzumab Deruxtecan Sales by Dosage Form (2021-2026) & (Units)
Table 20. Global Fam-Trastuzumab Deruxtecan Sales Market Share by Dosage Form (2021-2026)
Table 21. Global Fam-Trastuzumab Deruxtecan Revenue by Dosage Form (2021-2026) & ($ million)
Table 22. Global Fam-Trastuzumab Deruxtecan Revenue Market Share by Dosage Form (2021-2026)
Table 23. Global Fam-Trastuzumab Deruxtecan Sale Price by Dosage Form (2021-2026) & (US$/Unit)
Table 24. Major Players of Innovator
Table 25. Major Players of Generic
Table 26. Global Fam-Trastuzumab Deruxtecan Sales by Production Technology (2021-2026) & (Units)
Table 27. Global Fam-Trastuzumab Deruxtecan Sales Market Share by Production Technology (2021-2026)
Table 28. Global Fam-Trastuzumab Deruxtecan Revenue by Production Technology (2021-2026) & ($ million)
Table 29. Global Fam-Trastuzumab Deruxtecan Revenue Market Share by Production Technology (2021-2026)
Table 30. Global Fam-Trastuzumab Deruxtecan Sale Price by Production Technology (2021-2026) & (US$/Unit)
Table 31. Global Fam-Trastuzumab Deruxtecan Sale by Application (2021-2026) & (Units)
Table 32. Global Fam-Trastuzumab Deruxtecan Sale Market Share by Application (2021-2026)
Table 33. Global Fam-Trastuzumab Deruxtecan Revenue by Application (2021-2026) & ($ million)
Table 34. Global Fam-Trastuzumab Deruxtecan Revenue Market Share by Application (2021-2026)
Table 35. Global Fam-Trastuzumab Deruxtecan Sale Price by Application (2021-2026) & (US$/Unit)
Table 36. Global Fam-Trastuzumab Deruxtecan Sales by Company (2021-2026) & (Units)
Table 37. Global Fam-Trastuzumab Deruxtecan Sales Market Share by Company (2021-2026)
Table 38. Global Fam-Trastuzumab Deruxtecan Revenue by Company (2021-2026) & ($ millions)
Table 39. Global Fam-Trastuzumab Deruxtecan Revenue Market Share by Company (2021-2026)
Table 40. Global Fam-Trastuzumab Deruxtecan Sale Price by Company (2021-2026) & (US$/Unit)
Table 41. Key Manufacturers Fam-Trastuzumab Deruxtecan Producing Area Distribution and Sales Area
Table 42. Players Fam-Trastuzumab Deruxtecan Products Offered
Table 43. Fam-Trastuzumab Deruxtecan Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 44. New Products and Potential Entrants
Table 45. Market M&A Activity & Strategy
Table 46. Global Fam-Trastuzumab Deruxtecan Sales by Geographic Region (2021-2026) & (Units)
Table 47. Global Fam-Trastuzumab Deruxtecan Sales Market Share Geographic Region (2021-2026)
Table 48. Global Fam-Trastuzumab Deruxtecan Revenue by Geographic Region (2021-2026) & ($ millions)
Table 49. Global Fam-Trastuzumab Deruxtecan Revenue Market Share by Geographic Region (2021-2026)
Table 50. Global Fam-Trastuzumab Deruxtecan Sales by Country/Region (2021-2026) & (Units)
Table 51. Global Fam-Trastuzumab Deruxtecan Sales Market Share by Country/Region (2021-2026)
Table 52. Global Fam-Trastuzumab Deruxtecan Revenue by Country/Region (2021-2026) & ($ millions)
Table 53. Global Fam-Trastuzumab Deruxtecan Revenue Market Share by Country/Region (2021-2026)
Table 54. Americas Fam-Trastuzumab Deruxtecan Sales by Country (2021-2026) & (Units)
Table 55. Americas Fam-Trastuzumab Deruxtecan Sales Market Share by Country (2021-2026)
Table 56. Americas Fam-Trastuzumab Deruxtecan Revenue by Country (2021-2026) & ($ millions)
Table 57. Americas Fam-Trastuzumab Deruxtecan Sales by Type (2021-2026) & (Units)
Table 58. Americas Fam-Trastuzumab Deruxtecan Sales by Application (2021-2026) & (Units)
Table 59. APAC Fam-Trastuzumab Deruxtecan Sales by Region (2021-2026) & (Units)
Table 60. APAC Fam-Trastuzumab Deruxtecan Sales Market Share by Region (2021-2026)
Table 61. APAC Fam-Trastuzumab Deruxtecan Revenue by Region (2021-2026) & ($ millions)
Table 62. APAC Fam-Trastuzumab Deruxtecan Sales by Type (2021-2026) & (Units)
Table 63. APAC Fam-Trastuzumab Deruxtecan Sales by Application (2021-2026) & (Units)
Table 64. Europe Fam-Trastuzumab Deruxtecan Sales by Country (2021-2026) & (Units)
Table 65. Europe Fam-Trastuzumab Deruxtecan Revenue by Country (2021-2026) & ($ millions)
Table 66. Europe Fam-Trastuzumab Deruxtecan Sales by Type (2021-2026) & (Units)
Table 67. Europe Fam-Trastuzumab Deruxtecan Sales by Application (2021-2026) & (Units)
Table 68. Middle East & Africa Fam-Trastuzumab Deruxtecan Sales by Country (2021-2026) & (Units)
Table 69. Middle East & Africa Fam-Trastuzumab Deruxtecan Revenue Market Share by Country (2021-2026)
Table 70. Middle East & Africa Fam-Trastuzumab Deruxtecan Sales by Type (2021-2026) & (Units)
Table 71. Middle East & Africa Fam-Trastuzumab Deruxtecan Sales by Application (2021-2026) & (Units)
Table 72. Key Market Drivers & Growth Opportunities of Fam-Trastuzumab Deruxtecan
Table 73. Key Market Challenges & Risks of Fam-Trastuzumab Deruxtecan
Table 74. Key Industry Trends of Fam-Trastuzumab Deruxtecan
Table 75. Fam-Trastuzumab Deruxtecan Raw Material
Table 76. Key Suppliers of Raw Materials
Table 77. Fam-Trastuzumab Deruxtecan Distributors List
Table 78. Fam-Trastuzumab Deruxtecan Customer List
Table 79. Global Fam-Trastuzumab Deruxtecan Sales Forecast by Region (2027-2032) & (Units)
Table 80. Global Fam-Trastuzumab Deruxtecan Revenue Forecast by Region (2027-2032) & ($ millions)
Table 81. Americas Fam-Trastuzumab Deruxtecan Sales Forecast by Country (2027-2032) & (Units)
Table 82. Americas Fam-Trastuzumab Deruxtecan Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 83. APAC Fam-Trastuzumab Deruxtecan Sales Forecast by Region (2027-2032) & (Units)
Table 84. APAC Fam-Trastuzumab Deruxtecan Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 85. Europe Fam-Trastuzumab Deruxtecan Sales Forecast by Country (2027-2032) & (Units)
Table 86. Europe Fam-Trastuzumab Deruxtecan Revenue Forecast by Country (2027-2032) & ($ millions)
Table 87. Middle East & Africa Fam-Trastuzumab Deruxtecan Sales Forecast by Country (2027-2032) & (Units)
Table 88. Middle East & Africa Fam-Trastuzumab Deruxtecan Revenue Forecast by Country (2027-2032) & ($ millions)
Table 89. Global Fam-Trastuzumab Deruxtecan Sales Forecast by Type (2027-2032) & (Units)
Table 90. Global Fam-Trastuzumab Deruxtecan Revenue Forecast by Type (2027-2032) & ($ millions)
Table 91. Global Fam-Trastuzumab Deruxtecan Sales Forecast by Application (2027-2032) & (Units)
Table 92. Global Fam-Trastuzumab Deruxtecan Revenue Forecast by Application (2027-2032) & ($ millions)
Table 93. Daiichi Sankyo Basic Information, Fam-Trastuzumab Deruxtecan Manufacturing Base, Sales Area and Its Competitors
Table 94. Daiichi Sankyo Fam-Trastuzumab Deruxtecan Product Portfolios and Specifications
Table 95. Daiichi Sankyo Fam-Trastuzumab Deruxtecan Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Daiichi Sankyo Main Business
Table 97. Daiichi Sankyo Latest Developments
Table 98. AstraZeneca Basic Information, Fam-Trastuzumab Deruxtecan Manufacturing Base, Sales Area and Its Competitors
Table 99. AstraZeneca Fam-Trastuzumab Deruxtecan Product Portfolios and Specifications
Table 100. AstraZeneca Fam-Trastuzumab Deruxtecan Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. AstraZeneca Main Business
Table 102. AstraZeneca Latest Developments
Table 1. Fam-Trastuzumab Deruxtecan Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Fam-Trastuzumab Deruxtecan Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 5.4 mg/kg
Table 4. Major Players of 6.4 mg/kg
Table 5. Global Fam-Trastuzumab Deruxtecan Sales by Type (2021-2026) & (Units)
Table 6. Global Fam-Trastuzumab Deruxtecan Sales Market Share by Type (2021-2026)
Table 7. Global Fam-Trastuzumab Deruxtecan Revenue by Type (2021-2026) & ($ million)
Table 8. Global Fam-Trastuzumab Deruxtecan Revenue Market Share by Type (2021-2026)
Table 9. Global Fam-Trastuzumab Deruxtecan Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of Monoclonal Antibody
Table 11. Major Players of Polyclonal Antibody
Table 12. Global Fam-Trastuzumab Deruxtecan Sales by Antibody Type (2021-2026) & (Units)
Table 13. Global Fam-Trastuzumab Deruxtecan Sales Market Share by Antibody Type (2021-2026)
Table 14. Global Fam-Trastuzumab Deruxtecan Revenue by Antibody Type (2021-2026) & ($ million)
Table 15. Global Fam-Trastuzumab Deruxtecan Revenue Market Share by Antibody Type (2021-2026)
Table 16. Global Fam-Trastuzumab Deruxtecan Sale Price by Antibody Type (2021-2026) & (US$/Unit)
Table 17. Major Players of Lyophilized Powder For Injection
Table 18. Major Players of Concentrate For Intravenous Infusion
Table 19. Global Fam-Trastuzumab Deruxtecan Sales by Dosage Form (2021-2026) & (Units)
Table 20. Global Fam-Trastuzumab Deruxtecan Sales Market Share by Dosage Form (2021-2026)
Table 21. Global Fam-Trastuzumab Deruxtecan Revenue by Dosage Form (2021-2026) & ($ million)
Table 22. Global Fam-Trastuzumab Deruxtecan Revenue Market Share by Dosage Form (2021-2026)
Table 23. Global Fam-Trastuzumab Deruxtecan Sale Price by Dosage Form (2021-2026) & (US$/Unit)
Table 24. Major Players of Innovator
Table 25. Major Players of Generic
Table 26. Global Fam-Trastuzumab Deruxtecan Sales by Production Technology (2021-2026) & (Units)
Table 27. Global Fam-Trastuzumab Deruxtecan Sales Market Share by Production Technology (2021-2026)
Table 28. Global Fam-Trastuzumab Deruxtecan Revenue by Production Technology (2021-2026) & ($ million)
Table 29. Global Fam-Trastuzumab Deruxtecan Revenue Market Share by Production Technology (2021-2026)
Table 30. Global Fam-Trastuzumab Deruxtecan Sale Price by Production Technology (2021-2026) & (US$/Unit)
Table 31. Global Fam-Trastuzumab Deruxtecan Sale by Application (2021-2026) & (Units)
Table 32. Global Fam-Trastuzumab Deruxtecan Sale Market Share by Application (2021-2026)
Table 33. Global Fam-Trastuzumab Deruxtecan Revenue by Application (2021-2026) & ($ million)
Table 34. Global Fam-Trastuzumab Deruxtecan Revenue Market Share by Application (2021-2026)
Table 35. Global Fam-Trastuzumab Deruxtecan Sale Price by Application (2021-2026) & (US$/Unit)
Table 36. Global Fam-Trastuzumab Deruxtecan Sales by Company (2021-2026) & (Units)
Table 37. Global Fam-Trastuzumab Deruxtecan Sales Market Share by Company (2021-2026)
Table 38. Global Fam-Trastuzumab Deruxtecan Revenue by Company (2021-2026) & ($ millions)
Table 39. Global Fam-Trastuzumab Deruxtecan Revenue Market Share by Company (2021-2026)
Table 40. Global Fam-Trastuzumab Deruxtecan Sale Price by Company (2021-2026) & (US$/Unit)
Table 41. Key Manufacturers Fam-Trastuzumab Deruxtecan Producing Area Distribution and Sales Area
Table 42. Players Fam-Trastuzumab Deruxtecan Products Offered
Table 43. Fam-Trastuzumab Deruxtecan Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 44. New Products and Potential Entrants
Table 45. Market M&A Activity & Strategy
Table 46. Global Fam-Trastuzumab Deruxtecan Sales by Geographic Region (2021-2026) & (Units)
Table 47. Global Fam-Trastuzumab Deruxtecan Sales Market Share Geographic Region (2021-2026)
Table 48. Global Fam-Trastuzumab Deruxtecan Revenue by Geographic Region (2021-2026) & ($ millions)
Table 49. Global Fam-Trastuzumab Deruxtecan Revenue Market Share by Geographic Region (2021-2026)
Table 50. Global Fam-Trastuzumab Deruxtecan Sales by Country/Region (2021-2026) & (Units)
Table 51. Global Fam-Trastuzumab Deruxtecan Sales Market Share by Country/Region (2021-2026)
Table 52. Global Fam-Trastuzumab Deruxtecan Revenue by Country/Region (2021-2026) & ($ millions)
Table 53. Global Fam-Trastuzumab Deruxtecan Revenue Market Share by Country/Region (2021-2026)
Table 54. Americas Fam-Trastuzumab Deruxtecan Sales by Country (2021-2026) & (Units)
Table 55. Americas Fam-Trastuzumab Deruxtecan Sales Market Share by Country (2021-2026)
Table 56. Americas Fam-Trastuzumab Deruxtecan Revenue by Country (2021-2026) & ($ millions)
Table 57. Americas Fam-Trastuzumab Deruxtecan Sales by Type (2021-2026) & (Units)
Table 58. Americas Fam-Trastuzumab Deruxtecan Sales by Application (2021-2026) & (Units)
Table 59. APAC Fam-Trastuzumab Deruxtecan Sales by Region (2021-2026) & (Units)
Table 60. APAC Fam-Trastuzumab Deruxtecan Sales Market Share by Region (2021-2026)
Table 61. APAC Fam-Trastuzumab Deruxtecan Revenue by Region (2021-2026) & ($ millions)
Table 62. APAC Fam-Trastuzumab Deruxtecan Sales by Type (2021-2026) & (Units)
Table 63. APAC Fam-Trastuzumab Deruxtecan Sales by Application (2021-2026) & (Units)
Table 64. Europe Fam-Trastuzumab Deruxtecan Sales by Country (2021-2026) & (Units)
Table 65. Europe Fam-Trastuzumab Deruxtecan Revenue by Country (2021-2026) & ($ millions)
Table 66. Europe Fam-Trastuzumab Deruxtecan Sales by Type (2021-2026) & (Units)
Table 67. Europe Fam-Trastuzumab Deruxtecan Sales by Application (2021-2026) & (Units)
Table 68. Middle East & Africa Fam-Trastuzumab Deruxtecan Sales by Country (2021-2026) & (Units)
Table 69. Middle East & Africa Fam-Trastuzumab Deruxtecan Revenue Market Share by Country (2021-2026)
Table 70. Middle East & Africa Fam-Trastuzumab Deruxtecan Sales by Type (2021-2026) & (Units)
Table 71. Middle East & Africa Fam-Trastuzumab Deruxtecan Sales by Application (2021-2026) & (Units)
Table 72. Key Market Drivers & Growth Opportunities of Fam-Trastuzumab Deruxtecan
Table 73. Key Market Challenges & Risks of Fam-Trastuzumab Deruxtecan
Table 74. Key Industry Trends of Fam-Trastuzumab Deruxtecan
Table 75. Fam-Trastuzumab Deruxtecan Raw Material
Table 76. Key Suppliers of Raw Materials
Table 77. Fam-Trastuzumab Deruxtecan Distributors List
Table 78. Fam-Trastuzumab Deruxtecan Customer List
Table 79. Global Fam-Trastuzumab Deruxtecan Sales Forecast by Region (2027-2032) & (Units)
Table 80. Global Fam-Trastuzumab Deruxtecan Revenue Forecast by Region (2027-2032) & ($ millions)
Table 81. Americas Fam-Trastuzumab Deruxtecan Sales Forecast by Country (2027-2032) & (Units)
Table 82. Americas Fam-Trastuzumab Deruxtecan Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 83. APAC Fam-Trastuzumab Deruxtecan Sales Forecast by Region (2027-2032) & (Units)
Table 84. APAC Fam-Trastuzumab Deruxtecan Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 85. Europe Fam-Trastuzumab Deruxtecan Sales Forecast by Country (2027-2032) & (Units)
Table 86. Europe Fam-Trastuzumab Deruxtecan Revenue Forecast by Country (2027-2032) & ($ millions)
Table 87. Middle East & Africa Fam-Trastuzumab Deruxtecan Sales Forecast by Country (2027-2032) & (Units)
Table 88. Middle East & Africa Fam-Trastuzumab Deruxtecan Revenue Forecast by Country (2027-2032) & ($ millions)
Table 89. Global Fam-Trastuzumab Deruxtecan Sales Forecast by Type (2027-2032) & (Units)
Table 90. Global Fam-Trastuzumab Deruxtecan Revenue Forecast by Type (2027-2032) & ($ millions)
Table 91. Global Fam-Trastuzumab Deruxtecan Sales Forecast by Application (2027-2032) & (Units)
Table 92. Global Fam-Trastuzumab Deruxtecan Revenue Forecast by Application (2027-2032) & ($ millions)
Table 93. Daiichi Sankyo Basic Information, Fam-Trastuzumab Deruxtecan Manufacturing Base, Sales Area and Its Competitors
Table 94. Daiichi Sankyo Fam-Trastuzumab Deruxtecan Product Portfolios and Specifications
Table 95. Daiichi Sankyo Fam-Trastuzumab Deruxtecan Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Daiichi Sankyo Main Business
Table 97. Daiichi Sankyo Latest Developments
Table 98. AstraZeneca Basic Information, Fam-Trastuzumab Deruxtecan Manufacturing Base, Sales Area and Its Competitors
Table 99. AstraZeneca Fam-Trastuzumab Deruxtecan Product Portfolios and Specifications
Table 100. AstraZeneca Fam-Trastuzumab Deruxtecan Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. AstraZeneca Main Business
Table 102. AstraZeneca Latest Developments
LIST OF FIGURES
Figure 1. Picture of Fam-Trastuzumab Deruxtecan
Figure 2. Fam-Trastuzumab Deruxtecan Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Fam-Trastuzumab Deruxtecan Sales Growth Rate 2021-2032 (Units)
Figure 7. Global Fam-Trastuzumab Deruxtecan Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Fam-Trastuzumab Deruxtecan Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Fam-Trastuzumab Deruxtecan Sales Market Share by Country/Region (2025)
Figure 10. Fam-Trastuzumab Deruxtecan Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 5.4 mg/kg
Figure 12. Product Picture of 6.4 mg/kg
Figure 13. Global Fam-Trastuzumab Deruxtecan Sales Market Share by Type in 2026
Figure 14. Global Fam-Trastuzumab Deruxtecan Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Monoclonal Antibody
Figure 16. Product Picture of Polyclonal Antibody
Figure 17. Global Fam-Trastuzumab Deruxtecan Sales Market Share by Antibody Type in 2026
Figure 18. Global Fam-Trastuzumab Deruxtecan Revenue Market Share by Antibody Type (2021-2026)
Figure 19. Product Picture of Lyophilized Powder For Injection
Figure 20. Product Picture of Concentrate For Intravenous Infusion
Figure 21. Global Fam-Trastuzumab Deruxtecan Sales Market Share by Dosage Form in 2026
Figure 22. Global Fam-Trastuzumab Deruxtecan Revenue Market Share by Dosage Form (2021-2026)
Figure 23. Product Picture of Innovator
Figure 24. Product Picture of Generic
Figure 25. Global Fam-Trastuzumab Deruxtecan Sales Market Share by Production Technology in 2026
Figure 26. Global Fam-Trastuzumab Deruxtecan Revenue Market Share by Production Technology (2021-2026)
Figure 27. Fam-Trastuzumab Deruxtecan Consumed in HER2-Positive Breast Cancer
Figure 28. Global Fam-Trastuzumab Deruxtecan Market: HER2-Positive Breast Cancer (2021-2026) & (Units)
Figure 29. Fam-Trastuzumab Deruxtecan Consumed in HER2-Positive Gastric and Gastroesophageal Junction Cancer
Figure 30. Global Fam-Trastuzumab Deruxtecan Market: HER2-Positive Gastric and Gastroesophageal Junction Cancer (2021-2026) & (Units)
Figure 31. Fam-Trastuzumab Deruxtecan Consumed in HER2-Mutant Non-Small Cell Lung Cancer
Figure 32. Global Fam-Trastuzumab Deruxtecan Market: HER2-Mutant Non-Small Cell Lung Cancer (2021-2026) & (Units)
Figure 33. Fam-Trastuzumab Deruxtecan Consumed in Others
Figure 34. Global Fam-Trastuzumab Deruxtecan Market: Others (2021-2026) & (Units)
Figure 35. Global Fam-Trastuzumab Deruxtecan Sale Market Share by Application (2025)
Figure 36. Global Fam-Trastuzumab Deruxtecan Revenue Market Share by Application in 2025
Figure 37. Fam-Trastuzumab Deruxtecan Sales by Company in 2025 (Units)
Figure 38. Global Fam-Trastuzumab Deruxtecan Sales Market Share by Company in 2025
Figure 39. Fam-Trastuzumab Deruxtecan Revenue by Company in 2025 ($ millions)
Figure 40. Global Fam-Trastuzumab Deruxtecan Revenue Market Share by Company in 2025
Figure 41. Global Fam-Trastuzumab Deruxtecan Sales Market Share by Geographic Region (2021-2026)
Figure 42. Global Fam-Trastuzumab Deruxtecan Revenue Market Share by Geographic Region in 2025
Figure 43. Americas Fam-Trastuzumab Deruxtecan Sales 2021-2026 (Units)
Figure 44. Americas Fam-Trastuzumab Deruxtecan Revenue 2021-2026 ($ millions)
Figure 45. APAC Fam-Trastuzumab Deruxtecan Sales 2021-2026 (Units)
Figure 46. APAC Fam-Trastuzumab Deruxtecan Revenue 2021-2026 ($ millions)
Figure 47. Europe Fam-Trastuzumab Deruxtecan Sales 2021-2026 (Units)
Figure 48. Europe Fam-Trastuzumab Deruxtecan Revenue 2021-2026 ($ millions)
Figure 49. Middle East & Africa Fam-Trastuzumab Deruxtecan Sales 2021-2026 (Units)
Figure 50. Middle East & Africa Fam-Trastuzumab Deruxtecan Revenue 2021-2026 ($ millions)
Figure 51. Americas Fam-Trastuzumab Deruxtecan Sales Market Share by Country in 2025
Figure 52. Americas Fam-Trastuzumab Deruxtecan Revenue Market Share by Country (2021-2026)
Figure 53. Americas Fam-Trastuzumab Deruxtecan Sales Market Share by Type (2021-2026)
Figure 54. Americas Fam-Trastuzumab Deruxtecan Sales Market Share by Application (2021-2026)
Figure 55. United States Fam-Trastuzumab Deruxtecan Revenue Growth 2021-2026 ($ millions)
Figure 56. Canada Fam-Trastuzumab Deruxtecan Revenue Growth 2021-2026 ($ millions)
Figure 57. Mexico Fam-Trastuzumab Deruxtecan Revenue Growth 2021-2026 ($ millions)
Figure 58. Brazil Fam-Trastuzumab Deruxtecan Revenue Growth 2021-2026 ($ millions)
Figure 59. APAC Fam-Trastuzumab Deruxtecan Sales Market Share by Region in 2025
Figure 60. APAC Fam-Trastuzumab Deruxtecan Revenue Market Share by Region (2021-2026)
Figure 61. APAC Fam-Trastuzumab Deruxtecan Sales Market Share by Type (2021-2026)
Figure 62. APAC Fam-Trastuzumab Deruxtecan Sales Market Share by Application (2021-2026)
Figure 63. China Fam-Trastuzumab Deruxtecan Revenue Growth 2021-2026 ($ millions)
Figure 64. Japan Fam-Trastuzumab Deruxtecan Revenue Growth 2021-2026 ($ millions)
Figure 65. South Korea Fam-Trastuzumab Deruxtecan Revenue Growth 2021-2026 ($ millions)
Figure 66. Southeast Asia Fam-Trastuzumab Deruxtecan Revenue Growth 2021-2026 ($ millions)
Figure 67. India Fam-Trastuzumab Deruxtecan Revenue Growth 2021-2026 ($ millions)
Figure 68. Australia Fam-Trastuzumab Deruxtecan Revenue Growth 2021-2026 ($ millions)
Figure 69. China Taiwan Fam-Trastuzumab Deruxtecan Revenue Growth 2021-2026 ($ millions)
Figure 70. Europe Fam-Trastuzumab Deruxtecan Sales Market Share by Country in 2025
Figure 71. Europe Fam-Trastuzumab Deruxtecan Revenue Market Share by Country (2021-2026)
Figure 72. Europe Fam-Trastuzumab Deruxtecan Sales Market Share by Type (2021-2026)
Figure 73. Europe Fam-Trastuzumab Deruxtecan Sales Market Share by Application (2021-2026)
Figure 74. Germany Fam-Trastuzumab Deruxtecan Revenue Growth 2021-2026 ($ millions)
Figure 75. France Fam-Trastuzumab Deruxtecan Revenue Growth 2021-2026 ($ millions)
Figure 76. UK Fam-Trastuzumab Deruxtecan Revenue Growth 2021-2026 ($ millions)
Figure 77. Italy Fam-Trastuzumab Deruxtecan Revenue Growth 2021-2026 ($ millions)
Figure 78. Russia Fam-Trastuzumab Deruxtecan Revenue Growth 2021-2026 ($ millions)
Figure 79. Middle East & Africa Fam-Trastuzumab Deruxtecan Sales Market Share by Country (2021-2026)
Figure 80. Middle East & Africa Fam-Trastuzumab Deruxtecan Sales Market Share by Type (2021-2026)
Figure 81. Middle East & Africa Fam-Trastuzumab Deruxtecan Sales Market Share by Application (2021-2026)
Figure 82. Egypt Fam-Trastuzumab Deruxtecan Revenue Growth 2021-2026 ($ millions)
Figure 83. South Africa Fam-Trastuzumab Deruxtecan Revenue Growth 2021-2026 ($ millions)
Figure 84. Israel Fam-Trastuzumab Deruxtecan Revenue Growth 2021-2026 ($ millions)
Figure 85. Turkey Fam-Trastuzumab Deruxtecan Revenue Growth 2021-2026 ($ millions)
Figure 86. GCC Countries Fam-Trastuzumab Deruxtecan Revenue Growth 2021-2026 ($ millions)
Figure 87. Manufacturing Cost Structure Analysis of Fam-Trastuzumab Deruxtecan in 2026
Figure 88. Manufacturing Process Analysis of Fam-Trastuzumab Deruxtecan
Figure 89. Industry Chain Structure of Fam-Trastuzumab Deruxtecan
Figure 90. Channels of Distribution
Figure 91. Global Fam-Trastuzumab Deruxtecan Sales Market Forecast by Region (2027-2032)
Figure 92. Global Fam-Trastuzumab Deruxtecan Revenue Market Share Forecast by Region (2027-2032)
Figure 93. Global Fam-Trastuzumab Deruxtecan Sales Market Share Forecast by Type (2027-2032)
Figure 94. Global Fam-Trastuzumab Deruxtecan Revenue Market Share Forecast by Type (2027-2032)
Figure 95. Global Fam-Trastuzumab Deruxtecan Sales Market Share Forecast by Application (2027-2032)
Figure 96. Global Fam-Trastuzumab Deruxtecan Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Fam-Trastuzumab Deruxtecan
Figure 2. Fam-Trastuzumab Deruxtecan Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Fam-Trastuzumab Deruxtecan Sales Growth Rate 2021-2032 (Units)
Figure 7. Global Fam-Trastuzumab Deruxtecan Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Fam-Trastuzumab Deruxtecan Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Fam-Trastuzumab Deruxtecan Sales Market Share by Country/Region (2025)
Figure 10. Fam-Trastuzumab Deruxtecan Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 5.4 mg/kg
Figure 12. Product Picture of 6.4 mg/kg
Figure 13. Global Fam-Trastuzumab Deruxtecan Sales Market Share by Type in 2026
Figure 14. Global Fam-Trastuzumab Deruxtecan Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Monoclonal Antibody
Figure 16. Product Picture of Polyclonal Antibody
Figure 17. Global Fam-Trastuzumab Deruxtecan Sales Market Share by Antibody Type in 2026
Figure 18. Global Fam-Trastuzumab Deruxtecan Revenue Market Share by Antibody Type (2021-2026)
Figure 19. Product Picture of Lyophilized Powder For Injection
Figure 20. Product Picture of Concentrate For Intravenous Infusion
Figure 21. Global Fam-Trastuzumab Deruxtecan Sales Market Share by Dosage Form in 2026
Figure 22. Global Fam-Trastuzumab Deruxtecan Revenue Market Share by Dosage Form (2021-2026)
Figure 23. Product Picture of Innovator
Figure 24. Product Picture of Generic
Figure 25. Global Fam-Trastuzumab Deruxtecan Sales Market Share by Production Technology in 2026
Figure 26. Global Fam-Trastuzumab Deruxtecan Revenue Market Share by Production Technology (2021-2026)
Figure 27. Fam-Trastuzumab Deruxtecan Consumed in HER2-Positive Breast Cancer
Figure 28. Global Fam-Trastuzumab Deruxtecan Market: HER2-Positive Breast Cancer (2021-2026) & (Units)
Figure 29. Fam-Trastuzumab Deruxtecan Consumed in HER2-Positive Gastric and Gastroesophageal Junction Cancer
Figure 30. Global Fam-Trastuzumab Deruxtecan Market: HER2-Positive Gastric and Gastroesophageal Junction Cancer (2021-2026) & (Units)
Figure 31. Fam-Trastuzumab Deruxtecan Consumed in HER2-Mutant Non-Small Cell Lung Cancer
Figure 32. Global Fam-Trastuzumab Deruxtecan Market: HER2-Mutant Non-Small Cell Lung Cancer (2021-2026) & (Units)
Figure 33. Fam-Trastuzumab Deruxtecan Consumed in Others
Figure 34. Global Fam-Trastuzumab Deruxtecan Market: Others (2021-2026) & (Units)
Figure 35. Global Fam-Trastuzumab Deruxtecan Sale Market Share by Application (2025)
Figure 36. Global Fam-Trastuzumab Deruxtecan Revenue Market Share by Application in 2025
Figure 37. Fam-Trastuzumab Deruxtecan Sales by Company in 2025 (Units)
Figure 38. Global Fam-Trastuzumab Deruxtecan Sales Market Share by Company in 2025
Figure 39. Fam-Trastuzumab Deruxtecan Revenue by Company in 2025 ($ millions)
Figure 40. Global Fam-Trastuzumab Deruxtecan Revenue Market Share by Company in 2025
Figure 41. Global Fam-Trastuzumab Deruxtecan Sales Market Share by Geographic Region (2021-2026)
Figure 42. Global Fam-Trastuzumab Deruxtecan Revenue Market Share by Geographic Region in 2025
Figure 43. Americas Fam-Trastuzumab Deruxtecan Sales 2021-2026 (Units)
Figure 44. Americas Fam-Trastuzumab Deruxtecan Revenue 2021-2026 ($ millions)
Figure 45. APAC Fam-Trastuzumab Deruxtecan Sales 2021-2026 (Units)
Figure 46. APAC Fam-Trastuzumab Deruxtecan Revenue 2021-2026 ($ millions)
Figure 47. Europe Fam-Trastuzumab Deruxtecan Sales 2021-2026 (Units)
Figure 48. Europe Fam-Trastuzumab Deruxtecan Revenue 2021-2026 ($ millions)
Figure 49. Middle East & Africa Fam-Trastuzumab Deruxtecan Sales 2021-2026 (Units)
Figure 50. Middle East & Africa Fam-Trastuzumab Deruxtecan Revenue 2021-2026 ($ millions)
Figure 51. Americas Fam-Trastuzumab Deruxtecan Sales Market Share by Country in 2025
Figure 52. Americas Fam-Trastuzumab Deruxtecan Revenue Market Share by Country (2021-2026)
Figure 53. Americas Fam-Trastuzumab Deruxtecan Sales Market Share by Type (2021-2026)
Figure 54. Americas Fam-Trastuzumab Deruxtecan Sales Market Share by Application (2021-2026)
Figure 55. United States Fam-Trastuzumab Deruxtecan Revenue Growth 2021-2026 ($ millions)
Figure 56. Canada Fam-Trastuzumab Deruxtecan Revenue Growth 2021-2026 ($ millions)
Figure 57. Mexico Fam-Trastuzumab Deruxtecan Revenue Growth 2021-2026 ($ millions)
Figure 58. Brazil Fam-Trastuzumab Deruxtecan Revenue Growth 2021-2026 ($ millions)
Figure 59. APAC Fam-Trastuzumab Deruxtecan Sales Market Share by Region in 2025
Figure 60. APAC Fam-Trastuzumab Deruxtecan Revenue Market Share by Region (2021-2026)
Figure 61. APAC Fam-Trastuzumab Deruxtecan Sales Market Share by Type (2021-2026)
Figure 62. APAC Fam-Trastuzumab Deruxtecan Sales Market Share by Application (2021-2026)
Figure 63. China Fam-Trastuzumab Deruxtecan Revenue Growth 2021-2026 ($ millions)
Figure 64. Japan Fam-Trastuzumab Deruxtecan Revenue Growth 2021-2026 ($ millions)
Figure 65. South Korea Fam-Trastuzumab Deruxtecan Revenue Growth 2021-2026 ($ millions)
Figure 66. Southeast Asia Fam-Trastuzumab Deruxtecan Revenue Growth 2021-2026 ($ millions)
Figure 67. India Fam-Trastuzumab Deruxtecan Revenue Growth 2021-2026 ($ millions)
Figure 68. Australia Fam-Trastuzumab Deruxtecan Revenue Growth 2021-2026 ($ millions)
Figure 69. China Taiwan Fam-Trastuzumab Deruxtecan Revenue Growth 2021-2026 ($ millions)
Figure 70. Europe Fam-Trastuzumab Deruxtecan Sales Market Share by Country in 2025
Figure 71. Europe Fam-Trastuzumab Deruxtecan Revenue Market Share by Country (2021-2026)
Figure 72. Europe Fam-Trastuzumab Deruxtecan Sales Market Share by Type (2021-2026)
Figure 73. Europe Fam-Trastuzumab Deruxtecan Sales Market Share by Application (2021-2026)
Figure 74. Germany Fam-Trastuzumab Deruxtecan Revenue Growth 2021-2026 ($ millions)
Figure 75. France Fam-Trastuzumab Deruxtecan Revenue Growth 2021-2026 ($ millions)
Figure 76. UK Fam-Trastuzumab Deruxtecan Revenue Growth 2021-2026 ($ millions)
Figure 77. Italy Fam-Trastuzumab Deruxtecan Revenue Growth 2021-2026 ($ millions)
Figure 78. Russia Fam-Trastuzumab Deruxtecan Revenue Growth 2021-2026 ($ millions)
Figure 79. Middle East & Africa Fam-Trastuzumab Deruxtecan Sales Market Share by Country (2021-2026)
Figure 80. Middle East & Africa Fam-Trastuzumab Deruxtecan Sales Market Share by Type (2021-2026)
Figure 81. Middle East & Africa Fam-Trastuzumab Deruxtecan Sales Market Share by Application (2021-2026)
Figure 82. Egypt Fam-Trastuzumab Deruxtecan Revenue Growth 2021-2026 ($ millions)
Figure 83. South Africa Fam-Trastuzumab Deruxtecan Revenue Growth 2021-2026 ($ millions)
Figure 84. Israel Fam-Trastuzumab Deruxtecan Revenue Growth 2021-2026 ($ millions)
Figure 85. Turkey Fam-Trastuzumab Deruxtecan Revenue Growth 2021-2026 ($ millions)
Figure 86. GCC Countries Fam-Trastuzumab Deruxtecan Revenue Growth 2021-2026 ($ millions)
Figure 87. Manufacturing Cost Structure Analysis of Fam-Trastuzumab Deruxtecan in 2026
Figure 88. Manufacturing Process Analysis of Fam-Trastuzumab Deruxtecan
Figure 89. Industry Chain Structure of Fam-Trastuzumab Deruxtecan
Figure 90. Channels of Distribution
Figure 91. Global Fam-Trastuzumab Deruxtecan Sales Market Forecast by Region (2027-2032)
Figure 92. Global Fam-Trastuzumab Deruxtecan Revenue Market Share Forecast by Region (2027-2032)
Figure 93. Global Fam-Trastuzumab Deruxtecan Sales Market Share Forecast by Type (2027-2032)
Figure 94. Global Fam-Trastuzumab Deruxtecan Revenue Market Share Forecast by Type (2027-2032)
Figure 95. Global Fam-Trastuzumab Deruxtecan Sales Market Share Forecast by Application (2027-2032)
Figure 96. Global Fam-Trastuzumab Deruxtecan Revenue Market Share Forecast by Application (2027-2032)
